Solti-1801. Analysis of the efficacy of CDK4/6 inhibitors in combination with hormonal treatment in luminal breast cancer in relation to the intrinsic subtype and markers of immunity (CDK-PREDICT)-MedSci.cn

Solti-1801. Analysis of the efficacy of CDK4/6 inhibitors in combination with hormonal treatment in luminal breast cancer in relation to the intrinsic subtype and markers of immunity (CDK-PREDICT)

Tolosa, P; Pascual, T; Hernando, C; Servitja, S; Abad, MF; Villanueva, R; Henao, F; Benitez, J; Lema, L; Martinez, M; Ruano, Y; Parrilla, L; Bernardini, A; Roncero, AM; Pare, L; Canes, J; Salvador, F; Villagrasa, P; Prat, A; Ciruelos, E

CANCER RESEARCH, 2021; 81 (4):

科室
- - 订阅+
  - 更多科室
工具
服务